Hydrocortisone phosphate

Suppliers

Names

[ CAS No. ]:
3863-59-0

[ Name ]:
Hydrocortisone phosphate

[Synonym ]:
Cortisol 21-monophosphate
hydrocortone
Hydrocortisone phosphate
21-Hydrocortisonephosphoric acid
Cortisol phosphate
hydrocortisone 21-phosphate
Hydrocortisone dihydrogen phosphate
Cortisol 21-phosphate
hydrocortisone sodium phosphate
Cortisol 21-phosphoric acid
Hydrocortisone 21-(dihydrogen phosphate)
Corphos

Chemical & Physical Properties

[ Density]:
1.42g/cm3

[ Boiling Point ]:
669.9ºC at 760mmHg

[ Molecular Formula ]:
C21H31O8P

[ Molecular Weight ]:
442.44000

[ Flash Point ]:
358.9ºC

[ Exact Mass ]:
442.17600

[ PSA ]:
151.17000

[ LogP ]:
1.89860

[ Index of Refraction ]:
1.596

[ Storage condition ]:
2-8℃

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GM9005000
CHEMICAL NAME :
Cortisol, 21-(dihydrogen phosphate)
CAS REGISTRY NUMBER :
3863-59-0
LAST UPDATED :
199504
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C21-H31-O8-P
MOLECULAR WEIGHT :
442.49
WISWESSER LINE NOTATION :
L E5 B666 OV MUTJ A1 CQ E1 FV1OPQQO FQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
6 mg/kg
SEX/DURATION :
female 24-26 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - other effects to embryo
REFERENCE :
PEREBL Pediatric Research. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1967- Volume(issue)/page/year: 11,845,1977
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
450 mg/kg
SEX/DURATION :
female 8-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 12,195,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
1800 mg/kg
SEX/DURATION :
female 8-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 12,195,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
900 mg/kg
SEX/DURATION :
female 8-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 12,195,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
90 mg/kg
SEX/DURATION :
female 8-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
REFERENCE :
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7. Volume(issue)/page/year: 15,238,1975 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X6661 No. of Facilities: 10 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 7622 (estimated) No. of Female Employees: 7177 (estimated)

Related Compounds

  • Di-hydrocortisone phosphate
  • HYDROCORTISONE PHOSPHATE TRIETHYLAMINE
  • HYDROCORTISONE-[1,2,6,7-3H(N)]
  • diazene,(4-methoxyphenyl)(19,20,22,23-tetrahydro-12h-7,11-metheno-6h-dibenzo(b,k)(1,4,7,10,13)pentaoxacycloeicosin-25-yl)-,(e)
  • [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] pentanoate
  • HYDROCORTISONE-(1,2-3H(N))